Seagen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SEAGEN, and when can generic versions of SEAGEN drugs launch?
SEAGEN has one approved drug.
There are seven US patents protecting SEAGEN drugs.
There are one hundred and ninety-one patent family members on SEAGEN drugs in forty-five countries and seventeen supplementary protection certificates in fifteen countries.
Summary for Seagen
International Patents: | 191 |
US Patents: | 7 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Seagen: | See patent lawsuits for Seagen |
Drugs and US Patents for Seagen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | 11,207,324 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | 9,457,093 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | 9,457,093 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Seagen Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Malaysia | 169072 | ⤷ Try a Trial |
Croatia | P20171578 | ⤷ Try a Trial |
Russian Federation | 2428421 | ⤷ Try a Trial |
Singapore | 152230 | ⤷ Try a Trial |
Ukraine | 90659 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Seagen Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1971601 | C20210018 00331 | Estonia | ⤷ Try a Trial | PRODUCT NAME: TUKATINIIB;REG NO/DATE: EU/1/20/1526 12.02.2021 |
1971601 | 122021000042 | Germany | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB UND SEINE PHYSIOLOGISCH VERTRAEGLICHEN SALZE UND SOLVATE; REGISTRATION NO/DATE: EU/1/20/1526 20210211 |
1971601 | LUC00217 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB EVENTUELLEMENT SOUS FORME D'UN SEL OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE; AUTHORISATION NUMBER AND DATE: EU/1/20/1526 20210212 |
1971601 | 27/2021 | Austria | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB; REGISTRATION NO/DATE: EU/1/20/1526 (MITTEILUNG) 20210212 |
1971601 | CR 2021 00025 | Denmark | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT ELLER SOLVAT DERAF; REG. NO/DATE: EU/1/20/1526 20210212 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.